Balloon-occluded retrograde transvenous obliteration is feasible for prolonged portosystemic shunts after living donor liver transplantation

Yoshihiro Nagao, Tomohiko Akahoshi, hideo uehara, Naotaka Hashimoto, Nao Kinjo, Hirofumi Kawanaka, Morimasa Tomikawa, Hideaki Uchiyama, Tomoharu Yoshizumi, Yuji Soejima, Ken Shirabe, Yoshihiko Maehara

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purposes: The purpose of our study was to evaluate the efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) in patients after living donor liver transplantation (LDLT). Methods: Five patients with gastric varices (GVx) and/or liver dysfunction who were treated with B-RTO from January 2001 to December 2007 were enrolled in this study (GVx, n = 2; liver dysfunction, n = 1; both, n = 2). The eradication rate of the GVx, portal vein hemodynamics and improvement of liver function were evaluated. Results: B-RTO was performed successfully, and the GVx disappeared or decreased markedly in all patients. Recurrence of GVx was not observed during the follow-up. Significantly increased portal vein inflow and improved liver function were observed in all patients. Conclusions: B-RTO may be an effective treatment for patients after LDLT to prevent bleeding from GVx or to modulate portal vein inflow that is reduced by prolonged large portosystemic shunts.

Original languageEnglish
Pages (from-to)633-639
Number of pages7
JournalSurgery Today
Volume44
Issue number4
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Surgical Portasystemic Shunt
Living Donors
Liver Transplantation
Portal Vein
Liver Diseases
Esophageal and Gastric Varices
Liver
Hemodynamics
Hemorrhage
Recurrence

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Balloon-occluded retrograde transvenous obliteration is feasible for prolonged portosystemic shunts after living donor liver transplantation. / Nagao, Yoshihiro; Akahoshi, Tomohiko; uehara, hideo; Hashimoto, Naotaka; Kinjo, Nao; Kawanaka, Hirofumi; Tomikawa, Morimasa; Uchiyama, Hideaki; Yoshizumi, Tomoharu; Soejima, Yuji; Shirabe, Ken; Maehara, Yoshihiko.

In: Surgery Today, Vol. 44, No. 4, 01.01.2014, p. 633-639.

Research output: Contribution to journalArticle

Nagao, Yoshihiro ; Akahoshi, Tomohiko ; uehara, hideo ; Hashimoto, Naotaka ; Kinjo, Nao ; Kawanaka, Hirofumi ; Tomikawa, Morimasa ; Uchiyama, Hideaki ; Yoshizumi, Tomoharu ; Soejima, Yuji ; Shirabe, Ken ; Maehara, Yoshihiko. / Balloon-occluded retrograde transvenous obliteration is feasible for prolonged portosystemic shunts after living donor liver transplantation. In: Surgery Today. 2014 ; Vol. 44, No. 4. pp. 633-639.
@article{b4a8ddb2abb24af1813600a88ded52d3,
title = "Balloon-occluded retrograde transvenous obliteration is feasible for prolonged portosystemic shunts after living donor liver transplantation",
abstract = "Purposes: The purpose of our study was to evaluate the efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) in patients after living donor liver transplantation (LDLT). Methods: Five patients with gastric varices (GVx) and/or liver dysfunction who were treated with B-RTO from January 2001 to December 2007 were enrolled in this study (GVx, n = 2; liver dysfunction, n = 1; both, n = 2). The eradication rate of the GVx, portal vein hemodynamics and improvement of liver function were evaluated. Results: B-RTO was performed successfully, and the GVx disappeared or decreased markedly in all patients. Recurrence of GVx was not observed during the follow-up. Significantly increased portal vein inflow and improved liver function were observed in all patients. Conclusions: B-RTO may be an effective treatment for patients after LDLT to prevent bleeding from GVx or to modulate portal vein inflow that is reduced by prolonged large portosystemic shunts.",
author = "Yoshihiro Nagao and Tomohiko Akahoshi and hideo uehara and Naotaka Hashimoto and Nao Kinjo and Hirofumi Kawanaka and Morimasa Tomikawa and Hideaki Uchiyama and Tomoharu Yoshizumi and Yuji Soejima and Ken Shirabe and Yoshihiko Maehara",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s00595-013-0535-3",
language = "English",
volume = "44",
pages = "633--639",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Balloon-occluded retrograde transvenous obliteration is feasible for prolonged portosystemic shunts after living donor liver transplantation

AU - Nagao, Yoshihiro

AU - Akahoshi, Tomohiko

AU - uehara, hideo

AU - Hashimoto, Naotaka

AU - Kinjo, Nao

AU - Kawanaka, Hirofumi

AU - Tomikawa, Morimasa

AU - Uchiyama, Hideaki

AU - Yoshizumi, Tomoharu

AU - Soejima, Yuji

AU - Shirabe, Ken

AU - Maehara, Yoshihiko

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Purposes: The purpose of our study was to evaluate the efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) in patients after living donor liver transplantation (LDLT). Methods: Five patients with gastric varices (GVx) and/or liver dysfunction who were treated with B-RTO from January 2001 to December 2007 were enrolled in this study (GVx, n = 2; liver dysfunction, n = 1; both, n = 2). The eradication rate of the GVx, portal vein hemodynamics and improvement of liver function were evaluated. Results: B-RTO was performed successfully, and the GVx disappeared or decreased markedly in all patients. Recurrence of GVx was not observed during the follow-up. Significantly increased portal vein inflow and improved liver function were observed in all patients. Conclusions: B-RTO may be an effective treatment for patients after LDLT to prevent bleeding from GVx or to modulate portal vein inflow that is reduced by prolonged large portosystemic shunts.

AB - Purposes: The purpose of our study was to evaluate the efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) in patients after living donor liver transplantation (LDLT). Methods: Five patients with gastric varices (GVx) and/or liver dysfunction who were treated with B-RTO from January 2001 to December 2007 were enrolled in this study (GVx, n = 2; liver dysfunction, n = 1; both, n = 2). The eradication rate of the GVx, portal vein hemodynamics and improvement of liver function were evaluated. Results: B-RTO was performed successfully, and the GVx disappeared or decreased markedly in all patients. Recurrence of GVx was not observed during the follow-up. Significantly increased portal vein inflow and improved liver function were observed in all patients. Conclusions: B-RTO may be an effective treatment for patients after LDLT to prevent bleeding from GVx or to modulate portal vein inflow that is reduced by prolonged large portosystemic shunts.

UR - http://www.scopus.com/inward/record.url?scp=84896545773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896545773&partnerID=8YFLogxK

U2 - 10.1007/s00595-013-0535-3

DO - 10.1007/s00595-013-0535-3

M3 - Article

VL - 44

SP - 633

EP - 639

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 4

ER -